STOCK TITAN

[8-K] Navient Corporation Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

VirnetX Holding Corp. (VHC) filed a Form 4 reporting an automatic, non-discretionary insider transaction by Chief Scientist Robert D. Short III on 07/07/2025. The company withheld 50 common shares (Transaction Code F) at a price of $12.34 to satisfy payroll and income-tax obligations linked to previously granted restricted stock awards. The explanatory note confirms the transaction is strictly for tax settlement and does not involve an open-market sale.

Post-transaction ownership stands at 31,848 direct shares and 11,278 indirect shares held through The Short Revocable Living Trust, leaving Short’s overall economic exposure essentially unchanged. No derivative securities were exercised, acquired, or disposed of, and no other insider activity was disclosed. Given the immaterial size (≈0.1 % of Short’s total holdings) and its administrative nature, the filing carries limited investment significance and signals no shift in insider sentiment toward VirnetX.

VirnetX Holding Corp. (VHC) ha presentato un Modulo 4 che segnala una transazione automatica e non discrezionale da parte del Chief Scientist Robert D. Short III il 07/07/2025. La società ha trattenuto 50 azioni ordinarie (Codice Transazione F) al prezzo di $12,34 per adempiere agli obblighi fiscali e previdenziali legati a precedenti premi in azioni vincolate. La nota esplicativa conferma che la transazione è esclusivamente per la liquidazione fiscale e non comporta una vendita sul mercato aperto.

Dopo la transazione, la proprietà diretta ammonta a 31.848 azioni e quella indiretta a 11.278 azioni detenute tramite The Short Revocable Living Trust, mantenendo invariata l'esposizione economica complessiva di Short. Non sono stati esercitati, acquisiti o ceduti titoli derivati e non sono state divulgate altre attività da parte degli insider. Data la dimensione irrilevante (circa lo 0,1% del totale delle partecipazioni di Short) e la natura amministrativa, la comunicazione ha limitata rilevanza per gli investitori e non indica alcun cambiamento nel sentimento degli insider verso VirnetX.

VirnetX Holding Corp. (VHC) presentó un Formulario 4 reportando una transacción automática y no discrecional por parte del Científico Jefe Robert D. Short III el 07/07/2025. La empresa retuvo 50 acciones comunes (Código de Transacción F) a un precio de $12.34 para cumplir con obligaciones fiscales y de nómina relacionadas con premios en acciones restringidas previamente otorgadas. La nota explicativa confirma que la transacción es estrictamente para liquidación fiscal y no implica una venta en el mercado abierto.

Tras la transacción, la propiedad directa es de 31,848 acciones y la indirecta de 11,278 acciones mantenidas a través de The Short Revocable Living Trust, manteniendo esencialmente sin cambios la exposición económica total de Short. No se ejercieron, adquirieron ni dispusieron valores derivados, ni se reveló otra actividad de insiders. Dado el tamaño insignificante (≈0.1 % del total de participaciones de Short) y su naturaleza administrativa, la presentación tiene poca relevancia para la inversión y no señala ningún cambio en el sentimiento de los insiders hacia VirnetX.

VirnetX Holding Corp. (VHC)는 2025년 7월 7일 최고 과학자 Robert D. Short III의 자동적이고 비재량적인 내부자 거래를 보고하는 Form 4를 제출했습니다. 회사는 이전에 부여된 제한 주식 보상과 관련된 급여 및 소득세 의무를 충족하기 위해 50주 보통주(거래 코드 F)를 주당 $12.34에 원천징수했습니다. 설명 노트는 이 거래가 엄격히 세금 정산을 위한 것이며 공개 시장 매도는 포함되지 않는다고 확인합니다.

거래 후 직접 보유 주식은 31,848주, The Short Revocable Living Trust를 통한 간접 보유 주식은 11,278주로, Short의 전체 경제적 노출은 본질적으로 변함이 없습니다. 파생 증권의 행사, 취득 또는 처분은 없었으며, 다른 내부자 활동도 공개되지 않았습니다. 보유 총액의 약 0.1%에 불과한 미미한 규모와 행정적 성격으로 인해 이번 제출은 투자에 미치는 영향이 제한적이며 VirnetX에 대한 내부자들의 심리 변화도 나타내지 않습니다.

VirnetX Holding Corp. (VHC) a déposé un formulaire 4 rapportant une transaction interne automatique et non discrétionnaire effectuée par le Chief Scientist Robert D. Short III le 07/07/2025. La société a retenu 50 actions ordinaires (code de transaction F) au prix de 12,34 $ pour satisfaire aux obligations fiscales et de paie liées à des attributions d’actions restreintes précédemment accordées. La note explicative confirme que la transaction sert strictement à régler les impôts et n’implique pas de vente sur le marché libre.

Après la transaction, la détention directe s’élève à 31 848 actions et la détention indirecte à 11 278 actions via The Short Revocable Living Trust, laissant l’exposition économique globale de Short essentiellement inchangée. Aucun titre dérivé n’a été exercé, acquis ou cédé, et aucune autre activité d’initiés n’a été divulguée. Compte tenu de la taille négligeable (≈0,1 % des avoirs totaux de Short) et de la nature administrative, ce dépôt revêt une importance limitée pour les investisseurs et ne signale aucun changement dans le sentiment des initiés envers VirnetX.

VirnetX Holding Corp. (VHC) reichte am 07.07.2025 ein Formular 4 ein, das eine automatische, nicht diskretionäre Insider-Transaktion des Chief Scientist Robert D. Short III meldet. Das Unternehmen behielt 50 Stammaktien (Transaktionscode F) zum Preis von $12,34 ein, um Lohn- und Einkommenssteuerverpflichtungen im Zusammenhang mit zuvor gewährten eingeschränkten Aktienprämien zu erfüllen. Die Erläuterung bestätigt, dass die Transaktion ausschließlich der Steuerbegleichung dient und keinen Verkauf am offenen Markt beinhaltet.

Nach der Transaktion hält Short 31.848 direkte Aktien und 11.278 indirekte Aktien über den The Short Revocable Living Trust, wodurch sich seine wirtschaftliche Gesamtposition im Wesentlichen nicht ändert. Es wurden keine Derivate ausgeübt, erworben oder veräußert, und keine weiteren Insideraktivitäten wurden offengelegt. Aufgrund der unbedeutenden Größe (≈0,1 % von Shorts Gesamtbestand) und administrativen Natur hat die Meldung geringe investitionsbezogene Bedeutung und signalisiert keine Änderung der Insider-Stimmung gegenüber VirnetX.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Only 50 shares withheld for taxes; negligible impact and neutral signal.

The Code F designation reveals an automatic share surrender to cover tax obligations on vested stock, a routine event that does not reflect a discretionary buy or sell decision. Post-withholding, the insider still controls roughly 43 k shares, indicating sustained alignment with shareholders. Because the transaction involves less than 1 % of his position and no derivatives, liquidity or valuation impact is essentially nil. From a governance and sentiment perspective, the filing is neutral; it neither strengthens nor weakens the investment case for VHC.

VirnetX Holding Corp. (VHC) ha presentato un Modulo 4 che segnala una transazione automatica e non discrezionale da parte del Chief Scientist Robert D. Short III il 07/07/2025. La società ha trattenuto 50 azioni ordinarie (Codice Transazione F) al prezzo di $12,34 per adempiere agli obblighi fiscali e previdenziali legati a precedenti premi in azioni vincolate. La nota esplicativa conferma che la transazione è esclusivamente per la liquidazione fiscale e non comporta una vendita sul mercato aperto.

Dopo la transazione, la proprietà diretta ammonta a 31.848 azioni e quella indiretta a 11.278 azioni detenute tramite The Short Revocable Living Trust, mantenendo invariata l'esposizione economica complessiva di Short. Non sono stati esercitati, acquisiti o ceduti titoli derivati e non sono state divulgate altre attività da parte degli insider. Data la dimensione irrilevante (circa lo 0,1% del totale delle partecipazioni di Short) e la natura amministrativa, la comunicazione ha limitata rilevanza per gli investitori e non indica alcun cambiamento nel sentimento degli insider verso VirnetX.

VirnetX Holding Corp. (VHC) presentó un Formulario 4 reportando una transacción automática y no discrecional por parte del Científico Jefe Robert D. Short III el 07/07/2025. La empresa retuvo 50 acciones comunes (Código de Transacción F) a un precio de $12.34 para cumplir con obligaciones fiscales y de nómina relacionadas con premios en acciones restringidas previamente otorgadas. La nota explicativa confirma que la transacción es estrictamente para liquidación fiscal y no implica una venta en el mercado abierto.

Tras la transacción, la propiedad directa es de 31,848 acciones y la indirecta de 11,278 acciones mantenidas a través de The Short Revocable Living Trust, manteniendo esencialmente sin cambios la exposición económica total de Short. No se ejercieron, adquirieron ni dispusieron valores derivados, ni se reveló otra actividad de insiders. Dado el tamaño insignificante (≈0.1 % del total de participaciones de Short) y su naturaleza administrativa, la presentación tiene poca relevancia para la inversión y no señala ningún cambio en el sentimiento de los insiders hacia VirnetX.

VirnetX Holding Corp. (VHC)는 2025년 7월 7일 최고 과학자 Robert D. Short III의 자동적이고 비재량적인 내부자 거래를 보고하는 Form 4를 제출했습니다. 회사는 이전에 부여된 제한 주식 보상과 관련된 급여 및 소득세 의무를 충족하기 위해 50주 보통주(거래 코드 F)를 주당 $12.34에 원천징수했습니다. 설명 노트는 이 거래가 엄격히 세금 정산을 위한 것이며 공개 시장 매도는 포함되지 않는다고 확인합니다.

거래 후 직접 보유 주식은 31,848주, The Short Revocable Living Trust를 통한 간접 보유 주식은 11,278주로, Short의 전체 경제적 노출은 본질적으로 변함이 없습니다. 파생 증권의 행사, 취득 또는 처분은 없었으며, 다른 내부자 활동도 공개되지 않았습니다. 보유 총액의 약 0.1%에 불과한 미미한 규모와 행정적 성격으로 인해 이번 제출은 투자에 미치는 영향이 제한적이며 VirnetX에 대한 내부자들의 심리 변화도 나타내지 않습니다.

VirnetX Holding Corp. (VHC) a déposé un formulaire 4 rapportant une transaction interne automatique et non discrétionnaire effectuée par le Chief Scientist Robert D. Short III le 07/07/2025. La société a retenu 50 actions ordinaires (code de transaction F) au prix de 12,34 $ pour satisfaire aux obligations fiscales et de paie liées à des attributions d’actions restreintes précédemment accordées. La note explicative confirme que la transaction sert strictement à régler les impôts et n’implique pas de vente sur le marché libre.

Après la transaction, la détention directe s’élève à 31 848 actions et la détention indirecte à 11 278 actions via The Short Revocable Living Trust, laissant l’exposition économique globale de Short essentiellement inchangée. Aucun titre dérivé n’a été exercé, acquis ou cédé, et aucune autre activité d’initiés n’a été divulguée. Compte tenu de la taille négligeable (≈0,1 % des avoirs totaux de Short) et de la nature administrative, ce dépôt revêt une importance limitée pour les investisseurs et ne signale aucun changement dans le sentiment des initiés envers VirnetX.

VirnetX Holding Corp. (VHC) reichte am 07.07.2025 ein Formular 4 ein, das eine automatische, nicht diskretionäre Insider-Transaktion des Chief Scientist Robert D. Short III meldet. Das Unternehmen behielt 50 Stammaktien (Transaktionscode F) zum Preis von $12,34 ein, um Lohn- und Einkommenssteuerverpflichtungen im Zusammenhang mit zuvor gewährten eingeschränkten Aktienprämien zu erfüllen. Die Erläuterung bestätigt, dass die Transaktion ausschließlich der Steuerbegleichung dient und keinen Verkauf am offenen Markt beinhaltet.

Nach der Transaktion hält Short 31.848 direkte Aktien und 11.278 indirekte Aktien über den The Short Revocable Living Trust, wodurch sich seine wirtschaftliche Gesamtposition im Wesentlichen nicht ändert. Es wurden keine Derivate ausgeübt, erworben oder veräußert, und keine weiteren Insideraktivitäten wurden offengelegt. Aufgrund der unbedeutenden Größe (≈0,1 % von Shorts Gesamtbestand) und administrativen Natur hat die Meldung geringe investitionsbezogene Bedeutung und signalisiert keine Änderung der Insider-Stimmung gegenüber VirnetX.


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549



FORM 8-K



CURRENT REPORT

Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 7, 2025



Navient Corporation
(Exact name of registrant as specified in its charter)



Delaware
 
001-36228
  46-4054283
(State or other jurisdiction of incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)

13865 Sunrise Valley Drive, Herndon, Virginia
 
20171
(Address of principal executive offices)
 
(Zip Code)

Registrant’s telephone number, including area code (703) 810-3000

Not Applicable
(Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common stock, par value $.01 per share
NAVI
The Nasdaq Global Select Market
6% Senior Notes due December 15, 2043
JSM The Nasdaq Global Select Market
Preferred Stock Purchase Rights
None
The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
Compensatory Arrangements with Chief Executive Officer and President

Navient Corporation (the “Company”) and David L. Yowan, the Company’s Chief Executive Officer and President, entered into a letter agreement dated July 7, 2025 (the “Letter Agreement”) to amend their previous letter agreement (the “Prior Letter Agreement”) dated May 15, 2023, which was filed as Exhibit 99.1 to the Company’s Current Report on Form 8-K (File No. 001-36228) filed with the Securities and Exchange Commission (“SEC”) on May 16, 2023, as amended by an amendment to the Prior Letter Agreement (the “Amended Letter Agreement”) dated July 3, 2024, which was filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K (File No. 001-36228) filed with the SEC on July 5, 2024.

Pursuant to the Letter Agreement, Mr. Yowan’s annual base salary will increase to $1 million effective July 1, 2025.  Mr. Yowan will continue to be eligible to receive an annual bonus for 2025 pursuant to the Company’s Management Incentive Plan with a target bonus amount equal to 150% of his average annual base salary during the year.


Mr. Yowan will also be granted (1) an award of restricted stock units (“RSUs”) in respect of Company common shares, par value $0.01 (the “Common Stock”), equal to the quotient of $1.6 million divided by the closing price of the Common Stock on July 7, 2025 (the “Grant Date”), and (2) an award of performance-based restricted stock units (“PSUs”) in respect of Common Stock equal to the quotient of $2.4 million divided by the closing price of the Common Stock on the Grant Date.  The RSU award will vest as to (a) 50% of the RSUs, if Mr. Yowan remains employed by the Company through the first anniversary of the Grant Date, and (b) the remaining 50% of the RSUs if Mr. Yowan remains so employed through the eighteen (18) month anniversary of the Grant Date.  The RSUs will also vest in whole or in part if Mr. Yowan’s employment is terminated by the Company without cause or by Mr. Yowan for good reason.  Each vested RSU will be settled in cash in an amount equal to the fair market value of a share of Common Stock on the vesting date. The PSU award will vest as and to the extent that both a service condition and four independent performance goals (such performance goals together, the “performance condition”) are satisfied. The service condition will be satisfied as to (a) 50% of the PSUs if Mr. Yowan remains employed by the Company through the first anniversary of the Grant Date and (b) the remaining 50% of the PSUs if Mr. Yowan remains so employed through the eighteen (18) month anniversary of the Grant Date. The service condition will also be deemed satisfied if Mr. Yowan’s employment is terminated by the Company without cause or by Mr. Yowan for good reason.  The performance condition will be deemed satisfied with respect to (a) 45% of the PSUs based on a legacy expense target established for each of 2025, 2026 and 2027 (with the 2025 legacy expense target set forth in the Letter Agreement and the remaining targets to be established by the Company at the beginning of each respective year), with 15% of the PSUs eligible to vest with respect to each such annual target and (b) 55% of the PSUs based on the Company’s total shareholder return relative to peer companies over the three fiscal-year period 2025 through 2027 with payouts ranging from 0% to 150% of the PSUs for each performance goal.  The PSU award will be settled in shares of Common Stock.

All other terms and conditions contained in the Prior Letter Agreement, as amended by the Amended Letter Agreement, that are not specifically amended by the Letter Agreement shall remain unaffected and unamended by the Letter Agreement.

The foregoing description of the Letter Agreement is qualified in its entirety by the full text of the Letter Agreement, a copy of which is attached as Exhibit 10.1 hereto and incorporated by reference herein.

Item 9.01.
Financial Statements and Exhibits.

(d) Exhibits:

Exhibit
Number
Description
   
10.1
Letter Agreement, dated as of July 7, 2025, by and between Navient Corporation and David L. Yowan
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
NAVIENT CORPORATION
     
 
By:
/s/ Matthew Sheldon
 
Name:
Matthew Sheldon
 
Title:
Senior Vice President & General Counsel
     
Date: July 11, 2025
   



FAQ

What did VirnetX (VHC) disclose in the latest Form 4?

The company reported that Chief Scientist Robert D. Short III had 50 shares withheld on 07/07/2025 to cover tax obligations.

Was the 50-share transaction an open-market sale of VHC stock?

No. The shares were automatically withheld by VirnetX for taxes (Transaction Code F), not sold on the open market.

How many VirnetX shares does Robert D. Short III hold after the transaction?

He owns 31,848 shares directly and 11,278 shares indirectly via The Short Revocable Living Trust.

Did the filing report any derivative securities activity?

No derivative securities were acquired, exercised, or disposed of in this Form 4.

What is the investment significance of this Form 4 for VHC shareholders?

The filing is largely administrative; the small tax-withholding action does not indicate a change in insider sentiment or company outlook.
Navient Corporation

NASDAQ:NAVI

NAVI Rankings

NAVI Latest News

NAVI Latest SEC Filings

NAVI Stock Data

1.58B
98.51M
2.85%
104.75%
7.5%
Credit Services
Security Brokers, Dealers & Flotation Companies
Link
United States
HERNDON